2026 MEETING RESOURCES

ON-DEMAND INDEPENDENT SESSION I
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Wednesday, September 9, 2026
MTP I: AML7:00 AM - 7:45 AM
MTP II: ALL7:00 AM - 7:45 AM
MTP III: Lymphoma 17:00 AM - 7:45 AM
MTP IV: Lymphoma 27:00 AM - 7:45 AM
MTP V: CML7:00 AM - 7:45 AM
MTP VI: MPN7:00 AM - 7:45 AM
MTP VII: MDS7:00 AM - 7:45 AM
MTP VIII: MM7:00 AM - 7:45 AM
MTP IX: CLL7:00 AM - 7:45 AM
MTP X: Cellular Therapy7:00 AM - 7:45 AM
MTP XI: AML8:00 AM - 8:45 AM
MTP XII: ALL8:00 AM - 8:45 AM
MTP XIII: Lymphoma 1       8:00 AM - 8:45 AM
MTP XIV: Lymphoma 2 8:00 AM - 8:45 AM
MTP XV: CML8:00 AM - 8:45 AM
MTP XVI: MPN8:00 AM - 8:45 AM
MTP XVII: MDS 8:00 AM - 8:45 AM
MTP XVIII: MM8:00 AM - 8:45 AM
MTP XIX: CLL 8:00 AM - 8:45 AM
MTP XX: Cellular Therapy8:00 AM - 8:45 AM
Session I: Acute Lymphoblastic Leukemia9:15 AM - 11:41 AM
Independent Satellite Symposia I: Lunch12:11 PM - 1:11 PM
Independent Satellite Symposia II: Lunch12:11 PM - 1:11 PM
Independent Satellite Symposia III: Lunch12:11 PM - 1:11 PM
POSTER WALK I - ALL12:11 PM - 1:11 PM
POSTER WALK I - MDS12:11 PM - 1:11 PM
POSTER WALK I - AML 12:11 PM - 1:11 PM
Plenary Session I1:41 PM - 2:01 PM
Session II: Myelodysplastic Syndromes2:01 PM - 3:41 PM
Session III: Acute Myeloid Leukemia3:56 PM - 6:30 PM
POSTER SESSION, WELCOME & AWARDS (Non-Accredited)6:30 PM - 7:55 PM
Industry Expert Session I (Non-Accredited): Dinner7:55 PM - 8:55 PM
Thursday, September 10, 2026
Industry Expert Session II (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Breakfast with the Expert I6:45 AM - 7:45 AM
Session IV: Myeloproliferative Neoplasms8:15 AM - 9:55 AM
Session V: Chronic Myeloid Leukemia10:25 AM - 11:47 AM
Industry Expert Session III (Non-Accredited): Lunch12:17 PM - 1:17 PM
Industry Expert Session IV (Non-Accredited): Lunch12:17 PM - 1:17 PM
Industry Expert Session V (Non-Accredited): Lunch12:17 PM - 1:17 PM
POSTER WALK II - MPN12:17 PM - 1:17 PM
POSTER WALK II - CLL 12:17 PM - 1:17 PM
POSTER WALK II - CML12:17 PM - 1:17 PM
POSTER WALK II - MM12:17 PM - 1:17 PM
Plenary Session II1:47 PM - 2:07 PM
Session VI: Multiple Myeloma2:07 PM - 4:26 PM
Session VII: Chronic Lymphocytic Leukemia4:56 PM - 6:54 PM
Independent Satellite Symposia IV: Dinner7:04 PM - 8:04 PM
Independent Satellite Symposia V: Dinner7:04 PM - 8:04 PM
Independent Satellite Symposia VI: Dessert8:14 PM - 9:14 PM
Independent Satellite Symposia VII: Dessert8:14 PM - 9:14 PM
Friday, September 11, 2026
Breakfast with the Expert II6:45 AM - 7:45 AM
Industry Expert Session VI (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Session VIII: T-Cell Lymphoma8:15 AM - 9:55 AM
Session IX: Indolent B-Cell Lymphoma10:25 AM - 11:47 AM
Independent Satellite Symposia VIII: Lunch12:17 PM - 1:17 PM
Independent Satellite Symposia IX: Lunch12:17 PM - 1:17 PM
POSTER WALK III - ABCL12:17 PM - 1:17 PM
POSTER WALK III - HL12:17 PM - 1:17 PM
POSTER WALK III - TCL12:17 PM - 1:17 PM
POSTER WALK III - IBCL12:17 PM - 1:17 PM
POSTER WALK III - MCL12:17 PM - 1:17 PM
Plenary Session III1:47 PM - 2:07 PM
Session X: Aggressive B-Cell Lymphoma2:07 PM - 4:05 PM
Session XI: Mantle Cell Lymphoma4:35 PM - 5:57 PM
Session XII: Hodgkin Lymphoma6:12 PM - 6:58 PM
Industry Expert Session VII (Non-Accredited): Dinner7:08 PM - 8:08 PM
Industry Expert Session VIII (Non-Accredited): Dinner7:08 PM - 8:08 PM
Industry Expert Session IX (Non-Accredited): Dessert8:18 PM - 9:18 PM
Industry Expert Session X (Non-Accredited): Dessert8:18 PM - 9:18 PM
Saturday, September 12, 2026
Breakfast with the Expert III6:45 AM - 7:45 AM
Industry Expert Session XI (Non-Accredited): Breakfast6:45 AM - 7:45 AM
Session XIII: Cellular Therapy8:15 AM - 9:55 AM
Session XIV: Next Questions10:25 AM - 12:50 PM
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Dr. Olivier Hermine MD, PhD
Imagine Institute
Head of the Hematological Department 
Dr. Francesco Maura MD
Memorial Sloan Kettering Cancer Center
Assistant Attending
Dr. Petra Langerbeins MD
University of Cologne
Principal Investigator
Dr. Norbert Schmitz MD
University Hospital Muenster
Principal Investigator of Clinical Trial
Dr. Won Seog Kim MD, PhD
Samsung Medical Center
Professor, Division of Hematology/Oncology Samsung Medical Center
Dr. Enrica Marchi MD, PhD
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Dr. Paola Neri MD, PhD
University of Calgary
Associate Professor/Oncology
Dr. Jasmine M. Zain MD
Memorial Sloan Kettering Cancer Center
Attending Physician
Dr. Rob Pieters MD, MSc, PhD
Princess Máxima Center for Pediatric Oncology
Chief Medical Officer
Dr. Neal S. Young MD
National Cancer Institute
Hematology Branch, NHLBI/NIH
Dr. Bijal D. Shah MD, MS
H. Lee Moffitt Cancer Center
Senior Member, Clinical Research Medical Director for Hematologic Malignancies
Dr. LaQuisa Hill MD
Baylor College of Medicine
Associate Professor/ Internal Medicine; Section of Hematology/Oncology
Dr. Jonathon B. Cohen MD, MS
Emory University, Winship Cancer Institute
Professor, Hematology and Medical Oncology
Dr. Krina K. Patel MD, MSc
MD Anderson Cancer Center
Multiple Myeloma Section Chief, Associate Professor, Department of Lymphoma/Myeloma
Dr. Jeremy S. Abramson MD, MMSc
Massachusetts General Hospital
Professor of Medicine
Dr. Narendranath Epperla MD, MS, FACP
Huntsman Cancer Institute
Associate Professor
Dr. Roni Tamari MD
Memorial Sloan Kettering Cancer Center
Assistant Physician
Dr. Robert Z. Orlowski MD, PhD
MD Anderson Cancer Center
Chairman, Ad Interim, Director of Myeloma, and Professor of Medicine
Dr. Kristen O'Dwyer MD
University of Rochester Medical Center
Associate Professor
Dr. Paolo Caimi MD, MBA
Cleveland Clinic
Professor of Medicine